Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma

Table 1 Characteristics of the Subjects

variables	Control group	Basal cell hyperplasia	Dysplasia group	ESSC group	F/x²	p
Age, years	49 ± 8	53 ± 8	56 ± 7	58 ± 7	10.286	0.000*
Sex, M/F	18/15	24/13	28/19	28/15	1.155	0.764
Hypertension, Y/N	18/15	20/17	18/29	21/22	2.893	0.408
BMI, kg/m²	22.90 ± 2.72	22.93 ± 2.90	22.06 ± 2.60	21.73 ± 3.31	1.728	0.164
SBP, mmHg	132 ± 26	132 ± 19	131 ± 20	127 ± 17	0.549	0.649
DBP, mmHg	86 ± 14	85 ± 12	82 ± 12	78 ± 14	2.325	0.077
Smokers, Y/N	15/18	17/20	24/23	24/19	1.119	0.773
Drinkers, Y/N	15/18	24/13	24/23	23/20	2.890	0.409
Albumin, g/L	38 ± 3	44 ± 8	40 ± 6	38 ± 8	8.161	0.000*
TC, mmol/L	3.45 ± 1.09	3.63 ± 0.83	3.62 ± 0.80	2.54 ± 0.96	13.684	0.000*
TG, mmol/L	0.61 ± 0.43	0.68 ± 0.46	0.57 ± 0.40	0.50 ± 0.32	1.481	0.222
LDL, mmol/L	0.12 ± 0.33	0.08 ± 0.27	0.09 ± 0.28	0.23 ± 0.15	11.439	0.000*
HDL, mmol/L	0.77 ± 0.22	0.91 ± 0.22	0.85 ± 0.21	0.67 ± 0.24	8.667	0.000*
ADP, ng/L	10.27 ± 10.98	11.18 ± 13.10	14.33 ± 13.38	12.98 ± 11.79	0.850	0.469
oxLDL, ng/L	33.66 ± 11.54	27.40 ± 10.33	30.27 ± 11.83	23.94 ± 10.72	5.264	0.002*
oxLDL-ab, U/ml	38.33 ± 26.44	38.97 ± 21.38	32.52 ± 12.87	26.59 ± 7.88	4.210	0.007*
oxLDL-lgG, ng/ml	12.54 ± 4.67	18.14 ± 10.47	16.56 ± 8.42	10.23 ± 6.78	8.453	0.000*
oxLDL-lgM, ng/ml	20.56 ± 5.99	23.27 ± 6.17	24.63 ± 6.35	26.60 ± 5.88	6.402	0.000*

* p < 0.05; Abbreviations: ESSC, esophageal squamous cell carcinoma; MBI, body mass index; SBP, 0 systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; ADP, adiponectin; oxLDL, oxidized low-density lipoprotein; oxLDL-lgG, immunoglobulin G type of autoantibodies to oxidized low-density lipoprotein; oxLDL-lgM, immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein.

ISSN: 1476-511X